BeOne Medicines Schedules May 6 Release of Q1 2026 Unaudited Results and Audit Committee Review

Bulletin Express

04/22

BeOne Medicines Ltd. will disclose its unaudited financial results for the quarter ended 31 March 2026 on Wednesday, 6 May 2026, after Hong Kong market close. The statements will be prepared under U.S. GAAP and the applicable U.S. SEC rules.

On the same day, the company’s audit committee will meet to review and approve the first-quarter figures.

Management will host a results conference call at 8:00 a.m. U.S. Eastern Time (8:00 p.m. Hong Kong Time) on 6 May 2026. A live webcast and subsequently archived replay will be accessible through the investors section of the company’s website (https://ir.beonemedicines.com). Participants are advised to log in at least 15 minutes before the scheduled start.

The board of directors currently comprises Chairman and Executive Director John V. Oyler; Non-executive Director Dr. Xiaodong Wang; and Independent Non-executive Directors Dr. Olivier Brandicourt, Dr. Margaret Han Dugan, Michael Goller, Anthony C. Hooper, Ranjeev Krishana, Dr. Alessandro Riva, Dr. Corazon D. Sanders, Shalini Sharp and Qingqing Yi.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hans/news/1144446978"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1144446978\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1144446978?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-04-22 18:22","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1144446978","market":"us","top_or_hot":-1,"title":"BeOne Medicines Schedules May 6 Release of Q1 2026 Unaudited Results and Audit Committee Review","media":"Bulletin Express","content":"<p>BeOne Medicines Ltd. will disclose its unaudited financial results for the quarter ended 31 March 2026 on Wednesday, 6 May 2026, after Hong Kong market close. The statements will be prepared under U.S. GAAP and the applicable U.S. SEC rules.</p>\n<p>On the same day, the company’s audit committee will meet to review and approve the first-quarter figures.</p>\n<p>Management will host a results conference call at 8:00 a.m. U.S. Eastern Time (8:00 p.m. Hong Kong Time) on 6 May 2026. A live webcast and subsequently archived replay will be accessible through the investors section of the company’s website (https://ir.beonemedicines.com). Participants are advised to log in at least 15 minutes before the scheduled start.</p>\n<p>The board of directors currently comprises Chairman and Executive Director John V. Oyler; Non-executive Director Dr. Xiaodong Wang; and Independent Non-executive Directors Dr. Olivier Brandicourt, Dr. Margaret Han Dugan, Michael Goller, Anthony C. Hooper, Ranjeev Krishana, Dr. Alessandro Riva, Dr. Corazon D. Sanders, Shalini Sharp and Qingqing Yi.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BeOne Medicines Schedules May 6 Release of Q1 2026 Unaudited Results and Audit Committee Review</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBeOne Medicines Schedules May 6 Release of Q1 2026 Unaudited Results and Audit Committee Review\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-04-22 18:22</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>BeOne Medicines Ltd. will disclose its unaudited financial results for the quarter ended 31 March 2026 on Wednesday, 6 May 2026, after Hong Kong market close. The statements will be prepared under U.S. GAAP and the applicable U.S. SEC rules.</p>\n<p>On the same day, the company’s audit committee will meet to review and approve the first-quarter figures.</p>\n<p>Management will host a results conference call at 8:00 a.m. U.S. Eastern Time (8:00 p.m. Hong Kong Time) on 6 May 2026. A live webcast and subsequently archived replay will be accessible through the investors section of the company’s website (https://ir.beonemedicines.com). Participants are advised to log in at least 15 minutes before the scheduled start.</p>\n<p>The board of directors currently comprises Chairman and Executive Director John V. Oyler; Non-executive Director Dr. Xiaodong Wang; and Independent Non-executive Directors Dr. Olivier Brandicourt, Dr. Margaret Han Dugan, Michael Goller, Anthony C. Hooper, Ranjeev Krishana, Dr. Alessandro Riva, Dr. Corazon D. Sanders, Shalini Sharp and Qingqing Yi.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"06160","symbol_name":"百济神州","start_time":0,"source_url":"","article_id":"1144446978","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1144446978","pubTimestamp":1776853376,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"BeOne Medicines Ltd. will disclose its unaudited financial results for the quarter ended 31 March 2026 on Wednesday, 6 May 2026, after Hong Kong market close. The statements will be prepared under...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"06160":"百济神州"},"translate_title":"BeOne Medicines计划于5月6日发布2026年第一季度未经审计业绩和审计委员会审查","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"06160":1},"content_text":"BeOne Medicines Ltd. will disclose its unaudited financial results for the quarter ended 31 March 2026 on Wednesday, 6 May 2026, after Hong Kong market close. The statements will be prepared under U.S. GAAP and the applicable U.S. SEC rules.\nOn the same day, the company’s audit committee will meet to review and approve the first-quarter figures.\nManagement will host a results conference call at 8:00 a.m. U.S. Eastern Time (8:00 p.m. Hong Kong Time) on 6 May 2026. A live webcast and subsequently archived replay will be accessible through the investors section of the company’s website (https://ir.beonemedicines.com). Participants are advised to log in at least 15 minutes before the scheduled start.\nThe board of directors currently comprises Chairman and Executive Director John V. Oyler; Non-executive Director Dr. Xiaodong Wang; and Independent Non-executive Directors Dr. Olivier Brandicourt, Dr. Margaret Han Dugan, Michael Goller, Anthony C. Hooper, Ranjeev Krishana, Dr. Alessandro Riva, Dr. Corazon D. Sanders, Shalini Sharp and Qingqing Yi.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"dataReport,SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}